S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
All the trading advice you’ve ever received boils down to this (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers

H-CYTE Stock Price, News & Analysis (OTCMKTS:HCYTD)

$2.02
-1.98 (-49.50%)
(As of 07/11/2022)
Compare
Today's Range
$2.02
$2.77
50-Day Range
$2.02
$2.02
52-Week Range
$2.02
$77.00
Volume
400 shs
Average Volume
103 shs
Market Capitalization
$521,160.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HCYTD stock logo

About H-CYTE Stock (OTCMKTS:HCYTD)

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

HCYTD Stock Price History

HCYTD Stock News Headlines

Hyatt Hotels Corp Class A H
H-E-B Grocery Company
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
10-K: H-CYTE, INC.
HCYT H-CYTE, Inc.
H-CYTE Completes Acquisition of Jantibody
H-CYTE Announces 1-for-1,000 Reverse Stock Split
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Should You Refrigerate Peanut Butter?
H-CYTE Inc (HCYT)
H-CYTE Names Michael Yurkowsky Chief Executive Officer
Scanfil plc: Managers' transactions – Jokitalo
Robert Greif named Chief Executive Officer of H-CYTE
See More Headlines
Receive HCYTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H-CYTE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HCYTD
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-4,800,000.00
Net Margins
-450.40%
Pretax Margin
-450.40%

Debt

Sales & Book Value

Annual Sales
$1.61 million
Book Value
($31.45) per share

Miscellaneous

Free Float
244,000
Market Cap
$521,160.00
Optionable
Not Optionable
Beta
1.12
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Michael W. Yurkowsky (Age 50)
    CEO & Director
    Comp: $180k
  • Mr. Jeremy Daniel (Age 46)
    Chief Financial Officer
    Comp: $200k
  • Dr. Tanya Rhodes Ph.D. (Age 61)
    Chief Scientific Officer
    Comp: $252k
  • Mr. Jeffery Wright CPA (Age 39)
    CPA, Controller & Principal Accounting Officer














HCYTD Stock Analysis - Frequently Asked Questions

How have HCYTD shares performed in 2023?

H-CYTE's stock was trading at $2.02 at the start of the year. Since then, HCYTD shares have increased by 0.0% and is now trading at $2.02.
View the best growth stocks for 2023 here
.

How do I buy shares of H-CYTE?

Shares of HCYTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:HCYTD) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -